title: Psoriasis in adults and children: Kids are not just little people.
abstract: Pediatric psoriasis is a common skin disorder. Although pediatric psoriasis has many similarities to adult psoriasis, there are differences in presentation, particularly in infants. In addition, a more limited therapeutic armamentarium exists for children due to different inherent risks. Nearly all therapies are unapproved in the pediatric population, with far fewer pre- and postmarketing studies having been conducted. Despite these challenges, appropriate treatment should never be denied to a young patient, as physical and psychosocial ramifications of psoriasis in the school age child and adolescent are significant. A partnership with the patient, caregivers, and primary care providers is necessary and rewarding in meeting the challenges of this chronic, incurable disease. We address the presentation, treatment options, and counseling necessary when treating psoriasis in the pediatric population.
authors.affiliation: Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT.
authors.forename: Elle H
authors.initials: EH
authors.lastname: de Moll
authors.affiliation: Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT; Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT.
authors.forename: Mary Wu
authors.initials: MW
authors.lastname: Chang
authors.affiliation: Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: strober@uchc.edu.
authors.forename: Bruce
authors.initials: B
authors.lastname: Strober
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D015535:Arthritis, Psoriatic / Q000209:etiology; D001688:Biological Products / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D024821:Metabolic Syndrome / Q000209:etiology; D011565:Psoriasis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000532:radiotherapy; D014467:Ultraviolet Therapy; D055815:Young Adult
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents